Health Care Equipment

Tinavi

Tinavi released FY2026 Q1 earnings on April 28 After-Market (BJT), actual revenue CNY 52.72 M (forecast CNY 52.72 M), actual EPS CNY -0.1

Tinavi to Release FY2026 Q1 Earnings on April 29 After-Market (BJT)

Tinavi FY2025 Annual Earnings Release Scheduled for April 29, 2026 (BJT)

Tinavi released FY2025 Annual Earnings on February 27 (BJT), actual revenue CNY 278.82 M, actual EPS CNY -0.4

Tinavi released FY2025 Q4 earnings on February 27, 2026 (BJT) with actual revenue of CNY 91.34 M and EPS of CNY -0.1497

Tinavi released FY2025 Q3 earnings on October 29 After-Market (BJT), actual revenue CNY 62.16 M, actual EPS CNY -0.1169

Tinavi released FY2025 9 Months Earnings on October 29 After-Market BJT, actual revenue CNY 187.48 M, actual EPS CNY -0.2465

Tinavi to Release FY2025 Q3 Earnings on October 30 After-Market (BJT)

Tinavi released FY2025 Q2 earnings on August 27 After-Market BJT, actual revenue CNY 66.73 M, actual EPS CNY -0.0996

Tinavi released FY2025 Semi-Annual earnings on August 27 After-Market (BJT), actual revenue CNY 125.31 M, actual EPS CNY -0.13

Tinavi to Release FY2025 Semi-Annual Earnings on August 28, 2025 (BJT)

Tianzhinan Shareholders Sell 2.9896 Million Shares

Tiandhina Medical Holdings Hosts Investor Event for 'Shareholders Come'

Tianzhinan's Subsidiary Anhui AishiRui Raises Funds from Five Investors

Tianzhinan-U shareholders to sell up to 3% of shares

Tianzhia 航's shareholders plan to reduce holdings by no more than 1.5%

Tinavi released FY2024 Q4 earnings on April 28, 2025 (BJT) with actual revenue of CNY 86.72 M and EPS of CNY -0.0998

Tinavi released FY2024 Annual Earnings on April 28 (BJT), actual revenue CNY 178.84 M, actual EPS CNY -0.27

Tinavi released FY2025 Q1 earnings on April 28 After-Market (BJT), actual revenue CNY 58.58 M, actual EPS CNY -0.03

Tinavi FY2025 Q1 Earnings Release Scheduled for April 29, After-Market BJT

688277

Embodied AI startup Itshi Zhihang announced the completion of a financing round exceeding $450 million (approximately RMB 3 billion), once again breaking the record for a single funding round by a Chinese embodied AI startup

Wallstreetcn

Itshi Zhihang Completes Over $450 Million Financing Round, Valued at Approximately $1.8 Billion

QCraft recently completed a $100 million Series D financing round, with investors including leading domestic automakers and several investment institutions. The funds will be used for the research and development of physical AI technology and talent development. CEO Yu Qian stated that the company will shift its strategic focus to L4 autonomous driving and general physical AI, expecting to launch related technological solutions in 2026, and plans to conduct pilot projects and large-scale deployment in the Robotaxi field

雷帝触网

Qingzhou Zhihang completed a USD 100 million financing, Yu Qian: Strategic focus shifts to L4 and general physical AI

562600

159898

The domestic surgical robot industry is at a critical turning point from "concept validation" to "scale profitability." Zheshang Securities predicts that the market size of surgical robots in China will reach 7.2 billion yuan in 2024 and will surge to 76.7 billion yuan by 2032, with a compound annual growth rate of approximately 34%. Policy support and the expansion of overseas markets will drive rapid growth in the industry, with laparoscopic surgical robots accounting for 58% of the market. The orthopedic surgical robot market is also developing rapidly, with an expected compound annual growth rate of 41% from 2024 to 2032

ChinaAMC CSI All Share Health Care Devices ETF

China Merchants CSI All Share Medical Apparatus and Instruments ETF

How far have domestic surgical robots come?

Tinavi announced that the Advanced Manufacturing Fund and the Beijing-Tianjin-Hebei Fund plan to collectively reduce their holdings by no more than 3%. Specifically, the Advanced Manufacturing Fund will reduce its holdings by no more than 6.8399 million shares (accounting for 1.5% of the total share capital) through centralized bidding and block trading within three months after 15 trading days; the Beijing-Tianjin-Hebei Fund will also reduce its holdings by no more than 6.8399 million shares (accounting for 1.5% of the total share capital) during the same period

Zhitong

Tinavi: The Advanced Manufacturing Fund and the Beijing-Tianjin-Hebei Fund plan to collectively reduce their holdings by no more than 3% of shares

On September 26th, Jianfa Zhixin stated on the interactive platform that the products operated by the company include those related to medical surgical robots

Jianfa Zhixin: The products operated by the company include medical surgical robot-related products

At the press conference on September 9, the State Council Information Office introduced significant breakthroughs in China's new industrialization and real economy during the 14th Five-Year Plan period. Landmark achievements include the delivery of the C919 large passenger aircraft and the production license for the AG600 firefighting aircraft. The Long March 7 rocket successfully completed space logistics transportation, and advancements were made in deep drilling and shield tunneling technology. In addition, smart agricultural machinery and power equipment have enhanced food security and energy supply, while the Fuxing high-speed train and high-end medical equipment have improved people's livelihoods. In the future, efforts will continue to promote innovation in industrial foundations and technological equipment

During the "14th Five-Year Plan" period, these major national key projects continue to achieve breakthroughs

300760

688613

300633

002901

688114

The A-share medical device sector fluctuated and rose, with Allgens and United Imaging Healthcare increasing by over 10%. SONOSCAPE, MGI, Double Medical, Tinavi, and Mindray also followed suit

Mindray

Allgens

SONOSCAPE

Double Medical

Tinavi(688277.SH)